Literature DB >> 11934840

Leptin induces endothelin-1 in endothelial cells in vitro.

Peter Quehenberger1, Markus Exner, Raute Sunder-Plassmann, Katharina Ruzicka, Christian Bieglmayer, Georg Endler, Claudia Muellner, Wolfgang Speiser, Oswald Wagner.   

Abstract

Leptin, a protein encoded by the obese gene, is produced by adipocytes and released into the bloodstream. In obese humans, serum leptin levels are increased and correlate with the individual's body mass index and blood pressure. Elevated serum concentrations of endothelin-1 (ET-1), a potent vasoconstrictor and mitogen, were also observed in obese subjects. The pathomechanisms underlying this ET-1 increase in obesity are poorly understood. In the present study, we investigated the influence of the ob gene product leptin on the expression of ET-1 in human umbilical vein endothelial cells (HUVECs). Binding studies using (125)I-radiolabeled leptin revealed high- and low-affinity leptin binding sites on HUVECs (Kd1=13.1+/-3.1 nmol/L and Kd2=1390+/-198 nmol/L, respectively), mediating a time- and dose-dependent increase of ET-1 mRNA expression and protein secretion after incubation of HUVECs with leptin. This leptin-induced ET-1 expression was inhibited by preincubation of HUVECs with 0.75 micromol/L antisense phosphorothioate oligonucleotides directed against the leptin receptor Ob-Rb. Furthermore, after incubation with leptin, increased nuclear staining of c-fos and c-jun, the major components of the transcription factor AP-1, and increased AP-1 DNA binding were observed. Transient transfection studies with ET-1 promoter constructs showed that leptin-induced promoter activity was abolished in the absence of AP-1 binding sites or by cotransfection with a plasmid overexpressing a mutated jun, which is able to bind c-fos but not DNA. Thus, leptin upregulates ET-1 production in HUVECs via a mechanism potentially involving jun binding members of the bZIP family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934840     DOI: 10.1161/01.res.0000014226.74709.90

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

1.  Adipose tissue as regulator of vascular tone.

Authors:  Charlotte Boydens; Nele Maenhaut; Bart Pauwels; Kelly Decaluwé; Johan Van de Voorde
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 2.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Effects of leptin on cardiovascular physiology.

Authors:  Johnathan D Tune; Robert V Considine
Journal:  J Am Soc Hypertens       Date:  2007 Jul-Aug

Review 4.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

5.  Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues.

Authors:  Jaume Padilla; Nathan T Jenkins; Victoria J Vieira-Potter; M Harold Laughlin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

Review 6.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 7.  Role of endothelin-1 in hypertension.

Authors:  Marc Iglarz; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

8.  Adipose tissue and vascular phenotypic modulation by voluntary physical activity and dietary restriction in obese insulin-resistant OLETF rats.

Authors:  Jacqueline M Crissey; Nathan T Jenkins; Kasey A Lansford; Pamela K Thorne; David S Bayless; Victoria J Vieira-Potter; R Scott Rector; John P Thyfault; M Harold Laughlin; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

9.  Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer.

Authors:  Christos Yapijakis; Michael Kechagiadakis; Emeka Nkenke; Zoe Serefoglou; Dimitrios Avgoustidis; Antonis Vylliotis; Despina Perrea; Friedrich W Neukam; Efstratios Patsouris; Eleftherios Vairaktaris
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

10.  Blood pressure control and components of the metabolic syndrome: the GOOD survey.

Authors:  Walter Zidek; Lisa Naditch-Brûlé; Stefano Perlini; Csaba Farsang; Sverre E Kjeldsen
Journal:  Cardiovasc Diabetol       Date:  2009-09-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.